Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.

Risitano, Antonio M

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. [electronic resource] - Blood Apr 2009 - 4094-100 p. digital

Publication Type: Journal Article

1528-0020

10.1182/blood-2008-11-189944 doi


Antibodies, Monoclonal--immunology
Antibodies, Monoclonal, Humanized
Cell Survival
Complement C3--metabolism
Erythrocytes--metabolism
Female
Flow Cytometry
Hemoglobinuria, Paroxysmal--immunology
Humans
Immunotherapy
Male